|
KMID : 0338420220370061234
|
|
The Korean Journal of Internal Medicine
2022 Volume.37 No. 6 p.1234 ~ p.1240
|
|
|
Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19
|
|
Kim Ji-Yeun
Kwon Ji-Soo
Cha Hye-Hee
Lim So-Yun
Bae Seong-Man
Kim Sung-Han
|
|
|
Abstract
|
|
|
Background/Aims : The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19). We therefore compared the timing of adequate immune responses between the first and booster doses of COVID-19 vaccines in infection-naive healthcare workers.
Methods : We enrolled healthcare workers who received two doses of either the BNT162b2 vaccine or the ChAdOx1 vaccine, all of whom received the BNT162b2 vaccine as the booster (the third) dose. Spike 1 (S1)-immunoglobulin G (IgG) antibodies and interferon gamma producing T cell responses were measured at 0, 7, 14, and 21 days after the first dose, and at 0 and between 2 to 7 days after the booster dose.
Results : After the first-dose vaccination, the S1-IgG antibody responses were elicited within 14 days in the BNT162b2 group and within 21 days in the ChAdOx1 group. After the booster dose, the S1-IgG antibody responses were elicited within 5 days in both groups. The SARS-CoV-2-specific T cell responses appeared at 7 days after the first dose and at 4 days after the booster dose.
Conclusions : SARS-CoV-2-specific immune responses by memory B cells and T cells may be expected to appear around 4 to 5 days after the booster dose.
|
|
|
KEYWORD
|
|
|
Antibody formation, Primary, Secondary, COVID-19 vaccines
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|